Harpoon Therapeutics, Inc. Gains 35.15%
Thu, Dec 08, 2022 at 06:57 PM
Harpoon Therapeutics, Inc. (HARP:NASDAQ) jumped higher at $0.96, a gain of 35.1%. On Thu, Dec 08, 2022, HARP:NASDAQ hit a New 2-Week High of $0.96. The stock got featured on our News Catalysts scanner on Mon, Dec 05, 2022 at 08:09 AM in the 'INVESTOR UPDATE' category. From Fri, Nov 25, 2022, the stock recorded 66.67% Up Days and 40.00% Green Days
About Harpoon Therapeutics, Inc. (HARP:NASDAQ)
Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.
Top 10 Gainers:
- Pharvaris N.V. (PHVS:NASDAQ), 339.08%
- FedNat Holding Company (FNHC:NASDAQ), 90%
- Rent the Runway Inc. (RENT:NASDAQ), 74.26%
- Qutoutiao Inc. (QTT:NASDAQ), 55.32%
- Nymox Pharmaceutical Corporation (NYMX:NASDAQ), 48.87%
- Express, Inc. (EXPR:NYSE), 38.28%
- Esports Technologies Inc. (EBET:NASDAQ), 36.05%
- Tuniu Corporation (TOUR:NASDAQ), 35.8%
- Harpoon Therapeutics, Inc. (HARP:NASDAQ), 35.15%
- Carvana Co. (CVNA:NYSE), 29.5%